Baxter International (Mexico) Performance
| BAX Stock | MXN 638.00 8.41 1.30% |
The firm shows a Beta (market volatility) of 0.44, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Baxter International's returns are expected to increase less than the market. However, during the bear market, the loss of holding Baxter International is expected to be smaller as well. At this point, Baxter International has a negative expected return of -0.14%. Please make sure to confirm Baxter International's accumulation distribution, as well as the relationship between the day median price and price action indicator , to decide if Baxter International performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Baxter International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Begin Period Cash Flow | 3 B |
Baxter |
Baxter International Relative Risk vs. Return Landscape
If you would invest 69,727 in Baxter International on September 13, 2024 and sell it today you would lose (5,927) from holding Baxter International or give up 8.5% of portfolio value over 90 days. Baxter International is producing return of less than zero assuming 1.1157% volatility of returns over the 90 days investment horizon. Simply put, 9% of all stocks have less volatile historical return distribution than Baxter International, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Baxter International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Baxter International's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Baxter International, and traders can use it to determine the average amount a Baxter International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1247
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BAX |
Estimated Market Risk
| 1.12 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Baxter International is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Baxter International by adding Baxter International to a well-diversified portfolio.
Baxter International Fundamentals Growth
Baxter Stock prices reflect investors' perceptions of the future prospects and financial health of Baxter International, and Baxter International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Baxter Stock performance.
| Return On Equity | -0.32 | |||
| Return On Asset | 0.0375 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 823.56 B | |||
| Shares Outstanding | 504.67 M | |||
| Price To Earning | 504.96 X | |||
| Price To Book | 4.85 X | |||
| Price To Sales | 34.09 X | |||
| Revenue | 15.11 B | |||
| EBITDA | (535 M) | |||
| Cash And Equivalents | 1.91 B | |||
| Cash Per Share | 3.74 X | |||
| Total Debt | 15.23 B | |||
| Debt To Equity | 62.30 % | |||
| Book Value Per Share | 11.56 X | |||
| Cash Flow From Operations | 1.21 B | |||
| Earnings Per Share | 28.82 X | |||
| Total Asset | 28.29 B | |||
About Baxter International Performance
Evaluating Baxter International's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Baxter International has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Baxter International has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. Baxter International operates under Medical Instruments Supplies classification in Mexico and is traded on Mexico Stock Exchange. It employs 50000 people.Things to note about Baxter International performance evaluation
Checking the ongoing alerts about Baxter International for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Baxter International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Baxter International generated a negative expected return over the last 90 days | |
| The company has 15.23 Billion in debt which may indicate that it relies heavily on debt financing | |
| The company reported the revenue of 15.11 B. Net Loss for the year was (2.43 B) with profit before overhead, payroll, taxes, and interest of 6.03 B. | |
| Over 87.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Baxter International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Baxter International's stock is overvalued or undervalued compared to its peers.
- Examining Baxter International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Baxter International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Baxter International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Baxter International's stock. These opinions can provide insight into Baxter International's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Baxter Stock Analysis
When running Baxter International's price analysis, check to measure Baxter International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baxter International is operating at the current time. Most of Baxter International's value examination focuses on studying past and present price action to predict the probability of Baxter International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baxter International's price. Additionally, you may evaluate how the addition of Baxter International to your portfolios can decrease your overall portfolio volatility.